Sunday, May 28, 2017 1:38:08 PM
No doubt she is heartbroken by it.
*. It's disrespectful no matter how she feels about it.
Quote:
Secondly it's very possible that clinical studies take more than two years
Pre-clinical animal studies to test the concept do not take 2 yrs. Animals are used since it's a quick turnaround.
* please let us know what tests they are doing and how often they need to be modified or repeated and how long this will take? Once again please present facts. Do you honestly believe Professor Simpson is not doing clinical studies? If so facts please
Quote:
and with the level of industrial theft in the world that early results might not be published until the full process is over.
That should give PMCB open ended cover to produce nothing for the next 20 yrs.
*It might also protect their intellectual property...which is our intellectual property. Would you rather it was stolen?
Quote:
And until that process is over how would you have something to patent?
The Melligen cells are already protected with a patent, with their use for diabetes. If any evil pharma performing "industrial theft" attempted to use Melligen cells plus: cell-in-a-box, cell-in-a-oblong container, cell inside nanobots... the evil ones would have to deal with the Melligen patent issue. So where are these pre-clinical studies?
*I am suggesting they are taking time and not being published till they are complete. Do you really think uts is a scammy little institution and Professor Simpson is a liar? Do you have any facts?
Quote:
Third, being listed as an inventor of the mellingen cells doesn't reduce Professor Simpsons integrity.
Who said it did?
*Your replies inferred it.
Quote:
Fourth, you provide no proof that the eminent doctors and clinics involved with pcmb are mercenary just because they work for pcmb as consultants.
When did they suddenly become mercenary? There's nothing diabolical about a medical expert accepting consulting money.
*Exactly my point. Thankyou. So nothing at all wrong with pcmb hiring them as consultants.
Quote:
Fifth, if I was offered 50,000 a year ... dr van Hoff ...
There ya go again. So Hoff is suppose to research the morality of some Microcrap scam, offering him money for Consulting? I invite the reader to Goog on him. Hoff is involved as management, or consulting in numerous private biotechs. And that's aside from his main gig in Arizona. Meanwhile PMCB issued pumps about him, as though he'd be spending 90% of his time consulting with PMCB. Yeah, sure.
*Any facts to say he would consult on something he thought was a scam?
Quote:
Sixth, not all people in the world do things just for money...The time of eminent medical professors and researchers is limited and valuable and they don't waste it.
*When you have some facts about pcmb only hiring doctors to use their names and reputations...and there's something wrong with this...let's go further.
In the meantime can we please show eminent professors and physicians some respect please? And back up comments which disparage them with facts?
Recent PMCB News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:06:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:28 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/04/2023 08:40:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:01:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/31/2023 09:18:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM